Profit- Starved Pharmaceutical Wholesale and Distribution Market is Entering Crucial Phase

PRLog (Press Release) - Aug 01, 2008 -
Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a report which finds that the pharmaceutical wholesale and distribution market is entering a critical phase.

The report, “The Pharmaceutical Wholesale and Distribution Industry Outlook & Analysis 2008” which is available at http://www.piribo.com/search/results.html?k=vis072&x=0&y=0 finds that this industry, which sees profit margins as low as 1-2%, in entering into a crucial phase as many key products are set to lose patent protection shortly.

The 136-page study examines and analyses the various factors affecting the wholesale and distribution industry. These include:

•   Drug counterfeiting
•   Direct-to-pharmacy distribution
•   Parallel trade
•   Canada and U.S. drug reimportation
•   Internet drugs: mail order and on-line pharmacies.

The report analyses the pharmaceutical wholesale and distribution industry and forecasts to 2013.

The publication critically evaluates the complex natures of wholesale-distribution and what kinds of strategies are involved. It evaluates the drivers and obstacles for the various healthcare stakeholders connected to the industry.

The study contains key information on the following essential aspects of the industry:

•    Forecast for the big three U.S. wholesalers from 2008-2013
•    Drivers and constraints facing the W&D market
•   Opportunities and threats facing the W&D market
•   Commercial prospects for the W&D market

“The Pharmaceutical Wholesale and Distribution Industry Outlook & Analysis
2008” is available in pdf format from Piribo.
For more information, go to:
http://www.piribo.com/publications/pharmacy/distribution/...

Piribo product ID: VIS072